Sonoma Biotherapeutics, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.sonomabio.com
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06361836
- Locations
- ๐บ๐ธ
Columbia University Irving Medical Center, New York, New York, United States
๐บ๐ธBrigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of Minnesota, Minneapolis, Minnesota, United States
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06201416
- Locations
- ๐บ๐ธ
UCSF Medical Center, San Francisco, California, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธMayo Clinic, Scottsdale, Arizona, United States
Study of Single Doses of SBT115301 in Healthy Participants
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05388981
- Locations
- ๐บ๐ธ
Celerion, Tempe, Arizona, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath